TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Astrazeneca AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
743,486
|
641,572
|
556,187 |
Financial expenses |
843
|
585
|
494 |
Earnings before taxes |
35,985
|
25,767
|
14,798 |
Total assets |
513,470
|
475,240
|
423,518 |
Current assets |
511,480
|
473,827
|
421,877 |
Current liabilities |
114,679
|
102,535
|
68,787 |
Equity capital |
398,031
|
372,705
|
352,450 |
- share capital |
115,050
![]() |
115,050
![]() |
115,050 |
Employees (average) | 86 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.5%
|
78.4%
|
83.2% |
Turnover per employee | 7,460 | ||
Profit as a percentage of turnover |
4.8%
|
4.0%
|
2.7% |
Return on assets (ROA) |
7.2%
|
5.5%
|
3.6% |
Current ratio |
446.0%
|
462.1%
|
613.3% |
Return on equity (ROE) |
9.0%
|
6.9%
|
4.2% |
Change turnover |
101,914
|
85,385
|
-27,487 |
Change turnover % |
16%
|
15%
|
-5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.